Navigation Links
Analysis of ASCO's QOPI® data finds significant improvement in performance on metrics for quality oncology care

In this News Digest:

Summary of a study being published online March 11, 2013, in the Journal of Clinical Oncology, analyzing self-reported data from 156 outpatient oncology practices participating in the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI) showing significant improvements in performance on certain measures for quality oncology cancer care over a four-year period.

Overall, mean normalized performance scores from participating practices rose from 71 to 85 percent between 2006 and 2010; improvements were especially profound on measures related to adoption of new clinical practice standards. Quote for attribution to Sandra M. Swain, MD, FACP, ASCO President.

An analysis of self-reported data from outpatient oncology practices that participated in the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI) found a significant increase in performance on quality measures for oncology care over a four-year period, especially in adopting new clinical practices. The study was published on March 11, in the Journal of Clinical Oncology.

QOPI is a voluntary, national quality self-assessment and improvement program that allows outpatient oncology practices to compare the care they provide against guideline recommendations. Participation in QOPI has been growing steadily since the program's inception in 2006; more than 800 practices have registered to date.

Researchers analyzed data from 156 oncology practices, finding that the mean normalized performance score improved from 71 to 85 percent between 2006 and 2010. A further review of the data found the following trends:

  • Practices perform well on numerous quality measures: For example, participating practices reported consistently high rates (90 percent or higher) of providing postoperative (adjuvant) chemotherapy for breast, colorectal and non-small cell lung cancers, as recommended. Adjuvant therapy is proven to extend survival and often offer cures for many patients with these cancers.
  • Improved uptake of new clinical practices: Mean scores of measures related to new clinical practices (based on new guidelines or clinical evidence) improved from 5 to 69 percent overall over four years. These new clinical practices include genetic testing for tumor molecular markers that predict response to treatment in patients with metastatic colorectal cancer (KRAS gene alterations before administering anti-EGFR therapy), adequate lymph node examination after surgery in colorectal cancer, testing for, and use of the anti-nausea drug aprepitant when certain chemotherapy regimens are administered.
  • There are opportunities for improvement for certain measures: Measures that assess smoking cessation and fertility preservation counseling (for patients undergoing treatment that could render them infertile) did not improve over time. Performance on these measures ranged from a high of 34 percent for smoking cessation counseling to a low of 6 percent for discussion of fertility preservation.

"These findings demonstrate that oncologists are consistently performing at high levels in many core areas of care and are quickly incorporating new standard tests and treatments into everyday practice," said lead author Michael N. Neuss, MD, chief medical officer at the Vanderbilt-Ingram Cancer Center and Chair of the QOPI Steering Group. "These data also show that participation in quality measurement programs, like QOPI, is correlated with substantial improvement in adherence to clinical practice standards."

QOPI holds its two semi-annual collection rounds in the spring and fall. The current analysis included 156 practices that participated in at least two collection rounds and reported data from 30 or more patient charts per round. Performance scores (rates of adherence to quality measures) were calculated for seven categories of quality measures (also known as QOPI modules; includes: core measures, symptom/toxicity management, care at end of life, non-Hodgkin's lymphoma, breast cancer, colorectal cancer, and non-small cell lung cancer), which collectively include more than 150 measures.

ASCO Perspective
Sandra M. Swain, MD, FACP, ASCO President

"This study further shows that participation in quality assessment programs like QOPI should provide reassurance to people living with cancer that they are receiving high quality care. Nearly 600 practices in the U.S. are already participating in QOPI in part because it provides a systematic process, library of diverse quality measures, collection tool, and reliable information to assess the care they provide. QOPI is also the gateway to QOPI-Certification which recognizes practices that demonstrate performance on designated QOPI measures and meet certification standards for quality and safe care."

Contact: Aaron Tallent
American Society of Clinical Oncology

Related medicine news :

1. Network analysis of the brain may explain features of autism
2. MinistryKeys: Using DISC Behavioral Analysis to Help Religious Organizations Achieve Goals for 2013
3. BRICS Mobility Aids and Transportation Equipment Market Analysis & 2018 Forecasts in New Research Report at
4. Rice University analysis links ozone levels, cardiac arrest
5. Deep genomic analysis identifies a micro RNA opponent for ovarian cancer
6. CT texture analysis of tumors may be a valuable biomarker in localized esophageal cancer
7. Re-Analysis Refutes Diet Guidelines Favoring Vegetable Fats
8. Economic analysis finds penicillin, not "the pill," may have launched the sexual revolution
9. Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at
10. U.S. Medical Waste Market Analysis: Treatment, Containment, Management and Disposal Products Reviewed in New Research Report at
11. New analysis examines stakes for Medicaid in upcoming fiscal cliff negotiations on Capitol Hill
Post Your Comments:
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... "My friend's ... his fists into his infected cheeks," said an inventor from Platteville, Colo. "I came ... skin problems." , He developed the UNTOUCHABLE to prevent a child from rubbing or ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... of anesthesia and pain management services, today announced its partnership with WPC ... integrates data from disparate systems and organizes the data into an aggregated data ...
(Date:10/13/2015)... ... ... According to an article published October 5th by the American ... weight with a bariatric procedure are much less likely to develop endometrial cancer, which ... from 40 to 50 percent of all endometrial cancer cases are caused by obesity, ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... solutions, announced today their sponsorship of the Microsoft Dynamics AXUG, GPUG and NAVUG ... Summit, GPUG Summit and NAVUG Summit are independent user conferences designed and led ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... provider of IBM software products, introduced a new company, RightSensorâ„¢ LLC, an Internet ... data communications capability. RightSensorâ„¢ provides a fully-managed approach for customers requiring sensor ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 2015 Health Gorilla ( ) today announced ... – a secure platform for clinical data and communications poised ... and manage healthcare in the US. The launch follows the ... combined total of $4.4M raised to date, with Data ... Ventures , Harris Barton , Orfin Ventures ...
(Date:10/13/2015)... , October 13, 2015 --> ... ,What can be expected from the Asthma and COPD Therapies ... rates? Visiongain ,s brand new report shows you potential ... ,  ,Our 309-page report provides 260 tables, charts, and graphs. ... future market prospects. Our new study lets you assess forecasted ...
(Date:10/13/2015)... SPRINGS, N.C. , Oct. 13, 2015  Yesterday ... NVS Influenza Vaccines Holly Springs manufacturing site located in ... Since 2014, the facility has produced Flucelvax ® ... has the potential for faster start-up and is not ... 2015 CSL Limited acquired the influenza vaccines business of ...
Breaking Medicine Technology: